|
|
Qualifications
|
French Patent Attorney
European Patent Attorney
|
|
|
|
|
Education
|
Master’s in Engineering (Ecole Polytechnique)
Ph.D. in Immunology at the Curie Institute (Université Paris VII)
MS. in Oncology (Université Paris XI), Gustave Roussy Institute
CEIPI Graduate (Distinction in Patents) |
|
|
|
|
|
|
|
|
|
|
Background
|
| Gabrielle FAURE-ANDRE joined REGIMBEAU in 2008. |
|
|
|
|
|
|
|
|
|
|
|
|
|
Technical and scientific fields
|
Immunology, Cellular biology, Molecular biology, Biotechnology, Agribusiness, Cosmetics, Drugs, Diagnostics |
|
|
|
|
|
|
|
| | Paris | | REGIMBEAU is organising a 5-day training seminar on "European Patents and Designs: The Essentials" for clients and foreign colleagues wishing to acquire a working knowledge of the specificities of patent and design procedures in Europe.
Contributions by Jérôme COLLIN, Sylvain THIVILLIER, Evelyne ROUX, Martine BLOCH-WEILL, Isabelle THILL, Nicolas BOUQUIN, Henri BOURGEOIS, Frédérique DURIEUX, Philippe BESSIERE, Armelle LEONARD, Gabrielle FAURE-ANDRE, Yves DE SAINT-PERN, Caroline HUGUET-BRAUN, Matthieu OBJOIS, Cécile PUECH, Anne SEIBEL, Guillaume SCHWAB. |
| | 20th Jun 2019 | |
| | Angers | | | Contribution by Gabrielle FAURE-ANDRE at the Business-Research Day with a presentation on the theme "New regulations related to the Nagoya Protocol". |
| | 31th Jan 2019 | |
| | | Paris | | | Contribution by Gabrielle FAURE-ANDRE on "Traditional Knowledge, Traditional Cultural Expression, Genetic Resources, Nagoya Protocol, Towards New Forms of Intellectual Property?" at the ASPI conference |
| | 20th Sept 2018 | |
| | Montpellier | | | REGIMBEAU is organising a conference on: "Issues of Biodiversity Laws on Access, Exploitation and Intellectual Property Associated with Genetic Resources in Biotechnology". Contribution by Claire NEIRAC and Alexandrine REY, PI Lawyers Law of the Living- CIRAD Montpellier, Armelle LEONARD, French & European Patent Attorney and Head of the Montpellier office, Philippe BESSIERE, French & European Patent Attorney and Head of the Toulouse office, Gabrielle FAURE-ANDRE, French & European Patent Attorney and Barbara CASADEWALL, Partner. |
| | 19th Jun 2018 | |
| | Angers | | | Participation of Gabrielle FAURE-ANDRE in the "Nagoya Protocol Conference and ABS (access and benefit-sharing): what impact on your supply of plant resources for plant variety selection, acquisition or development?" organized by Vegepolys |
| | 22th March 2018 | |
| | Paris | | | Participation of Gabrielle FAURE-ANDRE, IP Attorney, at the Conference entitled "The Nagoya Protocol, Biodiversity here and abroad" organized by FEBEA, PRODAROM, ASPA INGRECOS and UNITIS. This conference took place at IFIS (Boulogne-Billancourt) on January 16, 2018. Many speakers (representatives of industries and competent authorities) drew up a very complete picture of the implementation in France and abroad of the laws relating to access and benefit sharing in accordance with the European Regulation. Practical case studies closed this day. |
| | 16th Jan 2018 | |
| | Toulouse | | | REGIMBEAU is organising a conference on: “Issues in Biodiversity Laws on Access, Exploitation and Intellectual Property associated with Genetic Resources in Biotechnology” in association with the Pôle de Compétitivité Cancer-Bio-Santé. Contributions from Philippe BESSIERE and Gabrielle FAURE-ANDRE - REGIMBEAU, Bruno DAVID and Pierick ROUSSEAU - Pierre Fabre, Jean DONNENWIRTH - Pioneer Génétique, and Diogo COSTA-CUNHAET and Sarah BERET - l’Université Toulouse Capitole.
The presentation will be followed by a round table aminated by Philippe BESSIERE, with participation from Sandrine ROYANNAIS and Aurelié SUAREZ - Pierre Fabre, Jean DONNENWIRTH - Pioneer Génétique, and Denis BARRON - Nestlé. |
| | 7th Dec 2017 | |
| |
|
|
|
|
|
|
|
|
Know-how
|
Due Diligence - Strategy
IP Prosecution
Portfolio management
Freedom to operate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| | Romainville | | | Bioproduction of Immunotherapies |
| | Contribution by Cécile PUECH on "Patent battles over antibody production (Upstream Processing) and territory constraints." and participation of Gabrielle FAURE-ANDRE at the 4th edition Bioproduction of Immunotherapies |
|
|
| |
|
|
|
|
|
|
|